Healthcare Of Ontario Pension Plan Trust Fund Passage Bio, Inc. Transaction History

Healthcare Of Ontario Pension Plan Trust Fund

$40.7 Billion
Q3 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2022 Aug 11, 2022	SELL	$1.63 - $3.46 $253,790 - $538,722	-155,700 Reduced 43.74%	200,300 $473,000
Q1 2022 May 12, 2022	BUY	$2.66 - $6.49 $946,960 - $2.31 Million	356,000 New	356,000 $1.1 Million

Others Institutions Holding PASG

# of Institutions

Shares Held

38.7M

Call Options Held

7.7K

Put Options Held

Orbimed Advisors LLC San Diego, CA

9.82M
Shares

$6.48 Million
0.16% of portfolio
Lynx1 Capital Management LP San Juan, PR

8.43M
Shares

$5.56 Million
2.11% of portfolio
Vestal Point Capital, LP New York, NY

6.1M
Shares

$4.03 Million
0.32% of portfolio
New Leaf Venture Partners, L.L.C. New York, NY

2.5M
Shares

$1.65 Million
1.8% of portfolio
Erste Asset Management Gmb H Vienna, C4

2.46M
Shares

$1.62 Million
0.02% of portfolio

View Full List

About Passage BIO, Inc.

Ticker PASG
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,463,200
Market Cap $35.9M
Description
Passage Bio, Inc., a genetic medicines company, develops transformative therapies for central nervous system diseases. It develops PBGM01, which utilizes a proprietary, AAVhu68 capsid to deliver to the brain and peripheral tissues a functional GLB1 gene encoding lysosomal acid beta-galactosidase for infantile GM1; PBFT02, which utilizes an AAV1 ...

More about PASG

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Healthcare Of Ontario Pension Plan Trust Fund, based on Form 13F filings with the SEC.

News

Stay updated on Healthcare Of Ontario Pension Plan Trust Fund with notifications on news.

Account